Markolines Pavement Technologies Settles SEBI Order for ₹12.35 Lakh Over Regulatory Non-Compliance
Markolines Pavement Technologies Limited has settled a regulatory matter with SEBI for ₹12.35 lakh concerning non-compliance with fund utilization disclosure requirements under Regulation 32 of SEBI (LODR) Regulations, 2015. The settlement order, received on April 27, 2026, pertains to missed filings during 2021-22 when the company was new to listing compliances following its 2021 listing. The company has since undertaken corrective measures and enhanced compliance protocols, with management stating the penalty has no material impact on operations.

*this image is generated using AI for illustrative purposes only.
Markolines pavement technologies Limited has announced the settlement of a regulatory matter with the Securities and Exchange Board of India (SEBI) through an official disclosure made on April 30, 2026. The company received a settlement order from SEBI concerning alleged non-compliance with regulatory disclosure requirements under Regulation 32 of SEBI (LODR) Regulations, 2015.
Settlement Details and Financial Impact
The regulatory settlement involves a monetary penalty that the company has addressed through the SEBI Settlement Proceedings framework. Key financial and procedural aspects of the settlement include:
| Parameter: | Details |
|---|---|
| Settlement Amount: | ₹12.35 lakh |
| Order Receipt Date: | April 27, 2026 |
| Disclosure Date: | April 30, 2026 |
| Financial Impact: | No material impact on operations |
| Settlement Basis: | Without admission or denial of findings |
| Current Status: | Proceedings disposed of |
Nature of Regulatory Non-Compliance
The SEBI settlement order pertains to alleged violations involving delayed or missed submission of statements regarding deviation or variation in utilization of funds raised through public issue. The specific compliance issue occurred during the financial year 2021-22, relating to requirements under Regulation 32 of SEBI (LODR) Regulations, 2015.
According to the company's official disclosure, being relatively new to listing compliances and stock exchange system requirements following its 2021 listing, it inadvertently missed filing the Statement of Deviation of funds under Regulation 32. However, upon becoming aware of these omissions, the company promptly made the necessary submissions and responded to all communications from stock exchanges.
Regulatory Framework and Official Disclosure
SEBI passed the settlement order under the SEBI (Settlement Proceedings) Regulations, 2018, providing a framework for resolving regulatory matters without prolonged proceedings. The company made the disclosure pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015.
| Regulatory Aspect: | Details |
|---|---|
| Regulatory Authority: | Securities and Exchange Board of India (SEBI) |
| Applicable Regulation: | Regulation 32 of SEBI (LODR) Regulations, 2015 |
| Settlement Framework: | SEBI (Settlement Proceedings) Regulations, 2018 |
| Disclosure Regulation: | Regulation 30 of SEBI (LODR) Regulations, 2015 |
| BSE Scrip Code: | MARKOLINES |
| NSE Symbol: | MARKOLINES |
Corporate Compliance and Future Measures
Following the identification of compliance gaps, Markolines Pavement Technologies has undertaken comprehensive corrective measures to strengthen its regulatory adherence. The company has completed all necessary corrective filings to ensure full compliance with applicable requirements and has established enhanced compliance protocols.
The management emphasized in their official disclosure that the penalty amount is insignificant compared to the company's overall revenue and profitability, indicating minimal impact on business operations. The settlement concludes SEBI's proceedings in this matter, allowing the company to focus on its core business activities while maintaining strengthened compliance frameworks.
The company remains committed to ensuring full compliance with all applicable regulatory requirements going forward, having learned from this experience as a relatively new listed entity.
How will the enhanced compliance protocols implemented by Markolines impact their operational costs and administrative overhead going forward?
Could this SEBI settlement affect Markolines' ability to raise capital through future public offerings or impact investor confidence?
What specific measures has the company put in place to prevent similar regulatory oversights, and how will these be monitored?

































